Pmv Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -372 | -362 | ||
EBITDA | -25,129 | -21,517 | -19,798 | -17,184 |
EBIT | -25,168 | -21,888 | -20,170 | -17,546 |
Net Income | -23,000 | -19,226 | -1,213 | -15,270 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,717 | -16,840 | -1,602 | -16,778 |
Cash | 40,876 | 48,810 | 49,348 | 48,476 |
Basic Shares | 51,574 | 51,574 | 51,478 | 51,445 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,257 | -650 | -1,281 | |
EBITDA | -85,448 | -78,875 | -76,725 | -57,986 |
EBIT | -80,132 | -77,040 | -58,293 | |
Net Income | -58,709 | -68,960 | -73,317 | -57,846 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,170 | -188,133 | ||
Free Cash Flow | -51,937 | -56,619 | -71,744 | -47,920 |
Cash | 40,876 | 37,706 | 108,297 | 172,467 |
Basic Shares | 51,578 | 48,014 | 45,594 | 45,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.45 |
2024-09-30 | -$0.37 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.30 |
